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Babesia microti, a tick-transmitted, intraerythrocytic protozoan parasite circulating mainly among 
small mammals, is the primary cause of human babesiosis. While most cases are transmitted by Ixodes 
ticks, the disease may also be transmitted through blood transfusion and perinatally. A comprehensive 
analysis of genome composition, genetic diversity, and gene expression profiling of seven B. microti 
isolates revealed that genetic variation in isolates from the Northeast United States is almost 
exclusively associated with genes encoding the surface proteome and secretome of the parasite. 
Furthermore, we found that polymorphism is restricted to a small number of genes, which are highly 
expressed during infection. In order to identify pathogen-encoded factors involved in host-parasite 
interactions, we screened a proteome array comprised of 174 B. microti proteins, including several 
predicted members of the parasite secretome. Using this immuno-proteomic approach we identified 
several novel antigens that trigger strong host immune responses during the onset of infection. The 
genomic and immunological data presented herein provide the first insights into the determinants of 
B. microti interaction with its mammalian hosts and their relevance for understanding the selective 
pressures acting on parasite evolution.
Babesia microti, the primary etiologic agent of human babesiosis, is an emerging health threat worldwide and 
particularly in the United States. It circulates in a tick vector – mammalian reservoir host cycle, with humans 
as dead-end hosts. Transmission to humans is primarily effected by ticks in the genus Ixodes, but can also occur 
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through blood transfusion and, rarely, through transplacental transmission1. The first documented case of human 
babesiosis attributed to B. microti in the United States was reported in Nantucket Island, MA in 19692. Over the 
past decade, there has been a significant increase in the number of babesiosis cases among both immunocom-
promised and immunocompetent patients1–4. Patients with asplenia, HIV infection, cancer, hemoglobinopathy, 
organ transplantation, or those on immunosuppressive drugs or who acquire the infection through blood trans-
fusion, manifest particularly severe disease, sometimes requiring hospital admission and occasionally ending in 
death or prolonged relapsing illness1,4.
Current therapies for the treatment of human babesiosis consist of combinations of atovaquone plus azith-
romycin or quinine plus clindamycin1,5. Although these drugs have been extensively used in recent years, qui-
nine and clindamycin combination is associated with major side effects, and drug failure has been reported with 
atovaquone and azithromycin. In some cases treatment can be achieved with higher drug doses, longer treatment 
duration and/or exchange transfusion, while in others the use of alternative drugs is needed due to microbial 
resistance3,5–10. Furthermore, the mechanism by which these drugs exert their anti-Babesia activity has only 
recently begun to be elucidated. Recent studies using a short-term in vitro culture as well as immunocompromised 
mice have shown that, of the four drugs used for treatment of human babesiosis, only atovaquone shows efficacy 
against the parasite in mouse red blood cells both in vitro and in vivo11. These results, along with the shortcomings 
of available diagnostic tools to distinguish between past and active infection to prevent transfusion-transmitted 
babesiosis, have stimulated efforts to improve therapies and diagnostics11–19.
There is limited knowledge of B. microti diversity in the context of pathogenesis and host-pathogen interactions20–22. 
Similarly, it is uncertain how parasite variability and host adaptation may impact its virulence, its successful 
transmission to humans, and disease diagnosis and therapy. The paucity of information about this parasite is 
due in part to the lack of data on genetic variation among isolates, lack of a continuous in vitro culture system for 
propagation of the parasite in human or mouse red blood cells, as well as the absence of tools and resources to 
manipulate its genome in order to characterize gene function in microbial development and virulence.
Efforts aimed at understanding B. microti population diversity and structure, and differentiate between parasite 
genotypes, have in the past relied on the use of PCR amplification of the 18S rDNA, β -tubulin and the 
chaperonin-containing t-complex polypeptide 1 (CCT7) (reviewed in ref. 23). More recently, Goethert and col-
leagues used a genotyping approach based on variable number of tandem repeat loci and identified at least two 
major populations and shed new light on the mode of expansion of the parasite in southern New England24.
The first B. microti genome sequencing and analysis were conducted on an isolate named the R1 strain, which 
provided initial information about genome composition, structure, metabolism, and the phylogenetic placement 
of the species25,26. The availability of new sequencing technologies has made it possible to perform genome-wide 
profiling of genetic polymorphisms in a large number of species including several protozoan parasites27–31. These 
analyses have significantly improved our understanding of the diversity and evolution of these pathogens, pro-
vided insights into their virulence, host modulation and the genetic basis of drug resistance phenotypes, and 
helped to develop novel approaches for disease control and prevention, and informed public health policy32–37.
Herein we report a systematic and comprehensive study of the genetic and transcriptional diversity of seven 
B. microti isolates. Using data from genomic and transcriptomic analyses, we have re-annotated the entire genome 
of the reference B. microti R1 strain, characterized the genomic diversity among isolates, and identified the full 
complement of genes encoding the parasite’s secretome and surface proteome. We show that polymorphism in 
genes that encode secreted and surface proteins accounts for most of the variations found among the B. microti 
isolates analyzed. We generated and screened a protein array consisting of 174 B. microti proteins using sera from 
mice infected with B. microti and sera of uninfected mouse controls. We identified 30 new parasite antigens that 
trigger a strong host response and determined that some of these antigens are encoded by the genes that are most 
polymorphic among these isolates. The fact that the most highly expressed genes in B. microti are unique to this 
species suggests that it has evolved novel mechanisms for survival within human red blood cells and to interact 
with its mammalian host. The genetic patterns reported here are valuable tools for a better understanding of 
B. microti pathogenesis and mode of transmission, and may contribute to improve disease diagnosis and control.
Results
Genome variability among B. microti isolates. To advance our understanding of B. microti genetic 
diversity and adaptation to the host environment, we performed high-throughput, whole genome sequenc-
ing of seven B. microti isolates (Supplementary Table S1), re-sequenced the reference R1 strain, and generated 
RNAseq data from six of these isolates (Supplementary Table S2). All nucleic acid material was obtained from 
the intra-erythrocytic life cycle stage of parasites propagated in rodents. Nearly all (98.3%) of the 3,567 pro-
tein-coding genes in the B. microti genome were found to be expressed, as defined by an average RPKM ≥ 10 and 
≥ 4X coverage. Our analyses revealed that gene expression is highly correlated among isolates (0.81 < r < 0.94; 
Fig. 1), with intron-exon splice sites clearly defined in the vast majority of genes (http://jbrowse.igs.umaryland.
edu/b_microti). This information provided exceptional transcript resolution and made possible extensive man-
ual curation and validation of the structure of nearly all protein-coding genes, resulting in improved structural 
characterization of 52% of all these genes (Supplementary Tables S3–S5). The updated nuclear genome annotation 
consists of 3,615 genes, 3,567 of which encode proteins, making it one of the most gene-dense genomes identified 
so far among the Apicomplexa (Supplementary Table S3). The updated re-annotation identified 70 new genes, 
with changes to previously predicted genes being relatively minor. Based on RNAseq analysis, ~64% of all exons 
in the new annotation were correctly predicted in the original annotation and ~34% were re-annotated. Only 4% 
of all nucleotides that are part of protein-coding sequences had been incorrectly assigned to introns or intergenic 
regions in the original annotation (Supplementary Table S4). Remarkably, B. microti genes are characterized by 
a preponderance of unusually small introns ranging in size between 18 and 21 nucleotides (some of which are in 
frame), a rare occurrence among eukaryotes (Supplementary Fig. S1). We also performed deep sequencing of the 
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B. microti R1 isolate in order to validate the sequence of the reference genome. Only 36 differences were found 
(Tables 1 and 2), mostly associated with chromosome ends (78%). Of these, 35 are insertions/deletions (indels), 
with 25 being in intergenic regions. Nine of these differences (one SNP and eight indels) may correspond to 
sequencing errors in the original assembly, as the alternate variant was found not only in the R1 re-sequencing 
data but also in all seven newly sequenced B. microti isolates. The remaining 27 differences either also correspond 
to sequencing errors in the original assembly or else may have accumulated during passaging of the R1 isolate in 
gerbils.
Analysis of genetic variation among genomes revealed a remarkable dearth of genetic diversity (Tables 1 and 2, 
Fig. 2), despite the fact that the isolates were collected from different geographic areas, across several decades, 
and represent recent clinical infections as well as long-established lab strains (Supplementary Table S1). A total of 
889 variable positions, defined by either single nucleotide polymorphisms (SNPs) or short indels, were found in 
the 6,395,281 bp B. microti R1 genome assembly (Tables 1 and 2, Supplementary Table S8). The average pairwise 
difference between each isolate and the reference R1 is 588 SNPs (Table 1), corresponding to 0.9 SNPs/10Kb, a 
frequency over one order of magnitude lower than current SNP density estimates for the human malaria parasite 
Plasmodium falciparum38. The majority of the variable positions were found to be R1-specific, with 515 SNPs 
and 103 indels unique to this isolate (Tables 1 and 2, Supplementary Table S7, and Fig. 3A). On the other hand, 
only 262 variable sites (with SNP or indels) were found among the other seven genomes, with an average of 14 
mutations being unique to each isolate, and 150 shared by two or more isolates (Supplementary Table S6). SNPs 
were enriched in non-coding segments (Fig. 3B), which correspond to 26% of the genome but accumulated 
Figure 1. Gene expression profile is highly correlated among six isolates of B. microti. Gene expression is 
shown for genes across the four nuclear chromosomes of B. microti. The numbered concentric circles represent 
the following: 1) genes encoded in the forward and reverse strands (mostly grey), with the host-exposed, 
secretome genes color-coded (GPI-anchored in blue; secreted proteins, SEC, in orange; transmembrane 
proteins, TM, in pink), and rDNA genes highlighted (in green, in chromosome 3); (2) median gene expression 
level, in RPKM (shades of blue); (3–8) deviation from median expression level, respectively, in GI, ATCC 30222, 
ATCC PRA-99, GreenwichYale_Lab_Strain_1, Nan_Hs_2011_N11_50, and Naushon. The expression of most 
genes is very similar across isolates, as shown by the overall low color intensity in these six most inner circles, 
with some notable exceptions such as the subtelomeric transmembrane-encoding genes in chromosome 1, or 
the GPI-anchored proteins, shown at 6 o’clock, in chromosome 1. The secretome genes that fall among the 10% 
most highly expressed (red) and 10% least expressed (green) genes are marked with small circles outside each 
chromosome plot. Approximately 25% of the secretome genes fall into one of these two classes.
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~38% of all SNPs (Chi-square, P < 0.0001). The distribution of indels was even more skewed, with only 20% of 
all indels found in coding sequences (CDSs) and nearly half of them result in in-frame mutations. Of the 3568 
protein-coding genes, only 205 carried a combined total of 257 amino acid-altering mutations, including indels 
of length not a multiple of three, and non-synonymous, read-through or non-sense SNPs.
Twenty seven genes contain nearly one third of all non-synonymous mutations (31 SNPs) and indels (48 indels) 
(Figs 2 and 4). More than half of these 27 genes encode surface or secreted antigens, including five members of 
the BMN2 gene family, which accumulated 23 of the 257 non-synonymous mutations (Figs 2 and 4). The most 
variable gene identified in this analysis is BBM_04g09980, with 11 mutations, and is located in the sub-telomeric 
region of chromosome IV. This gene is also differentially expressed between isolates (Fig. 5). Interestingly, the 
intergenic regions flanking BBM_04g09980 are also highly polymorphic. Overall, our analyses revealed that chro-
mosome ends account for 9.3% of genome variations observed in the genome of B. microti (Fig. 6A). The genes 
in this region of the chromosomes are variable between strains (Fig. 6A) and are associated with the presence of 
indels. SNPs in these regions were often below the quality threshold applied for calling because of the presence of 
several sequences that are repeated multiple times. Sequencing of PCR products confirmed the scarcity of SNPs 
at chromosome ends.
Analysis of microsatellites in the genome of the B. microti isolates revealed 336 micro- and mini-satellites 
ranging in length between 2 and 375 bp. Among these, 12 are variable among strains with 8 found in coding 
sequences, 3 in intergenic regions, including previously described BMV424, and 1 in an intron. Clustering of the 
seven isolates based on these microsatellites showed that they form three major clusters one comprised of G1 and 
PRA-99, the second of Naushon, N11–50 and GreenwichYale_Lab_Strain_1 (LabS1), with the ATCC-30222 and 
the R1 isolate forming a sister group to the other isolates (Fig. 6B).
Identification of B. microti genes encoding components of the secretome and potentially under 
immune selection. To identify proteins of B. microti that might play a role in host-parasite interaction and 
Isolate
Total 
counta
Non coding region Coding region Unique SNPs Ambiguous
Inter-
genic Intronic
5′ UTR 
3′ UTR Syn.
Non-
syn.
RTH 
NON
Unique 
ALT
Unique 
REF QUAL UNC
R1b 1 1 0 0 0 0 0 0 515 0 0
ATCC_30222 523 106 49 33 163 170 2 25 0 22 0
ATCC_PRA-99 507 102 53 32 154 164 2 6 0 31 0
GI 528 106 53 33 163 171 2 6 0 7 0
Greenwich_Lab_Strain_1 456 85 44 30 146 149 2 3 0 79 1
Nan_Hs_2011_N11–50 524 104 54 33 164 167 2 5 0 12 0
Naushon 523 107 53 33 162 166 2 3 0 11 0
Bm1438 508 106 48 34 160 158 2 6 0 26 2
Total number of variable 
genomic positions 588 121 63 38 171 193 2 54 515 98 2
Table 1.  Distribution of SNPs relative to R1, in seven B. microti isolates and in the re-sequenced R1 isolate. 
aDifferences were identified against the R1 reference genome25. bR1 reference isolate was re-sequenced, using 
Illumina HiSeq technology, to identify potential errors in the original assembly. The sequence variants identified 
are based on these Illumina data mapped against the reference genome assembly.
Isolate
Total 
count
Non-coding region Coding region Unique SNPs
Inter-
genic Intronic 5′ UTR 3′ UTR SNP Indel x3 Other
Unique 
ALT
Unique 
REF
R1 35(10) 24(4) 2(1) 0 5 4 0 3 103
ATCC_30222 211(6) 107(1) 58(1) 10(0) 4 17 15 15 0
ATCC_PRA-99 210(7) 111(3) 57(1) 9(0) 3 16 14 1 0
GI 208(5) 112(2) 55(1) 9(0) 2 16 14 6 0
Greenwich_Lab_Strain_1 169(4) 84(3) 47(0) 8(0) 1 14 15 12 6
Nan_Hs_2011_N11-50 221(10) 117(5) 56(1) 9(0) 4 22 13 16 0
Naushon 212(4) 114(1) 52(1) 9(0) 2 16 19 2 0
Bm1438 176(10) 95(4) 54(2) 9(0) 4 13 1 3 1
Total number of variable genomic 
positions 301 160 69 10 NV 28 34 58 110
Table 2.  Distribution of positions with indels relative to R1, in at least one of the seven B. microti isolates 
and in the re-sequenced R1 isolatea. aThe table reports all genomic position where at least one strain contains 
an indel. Other isolates might present single point mutation (SNP) at the same position (shown in brackets). 
SNP counts were not included in the last row (Total number). NV: Not Valid. Indel x3: indels with length 
multiple of 3.
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immune modulation, we curated the proteome for all possible members of the B. microti secretome, including 
GPI-anchored, secreted and transmembrane proteins, based on primary sequence attributes as well as on homol-
ogy to members of the malarial secretome (Supplementary Table S8). B. microti proteins predicted to localize to 
intracellular organelles were excluded from this set (Fig. 7). The B. microti secretome consists of 420 proteins, 
19 of which are GPI-anchored (GPI), 196 are predicted to be soluble secreted proteins (SEC) and 205 associ-
ated with a membrane (TM). This set encompasses all previously described antigens such as the BmP94 antigen 
(BBM_04g08155), the maltese-cross seroactive antigen (BBM_04g07535), most of the BMN genes, and several 
Figure 2. Sequence variants are rare among eight B. microti isolates. Distribution of all SNPs relative to GI 
strain, across the variable genes in each of the four nuclear chromosomes of B. microti. In each chromosome 
plot, the numbered concentric circles represent: 1) genes encoded in the forward and reverse strands (black; 
rDNA genes in green, in chromosome 3), with loci with sequence variants in any of the strains expanded 5000X; 
(2) character state, for each variable site, in the GI strain; (3–9) SNPs shown relative to GI, respectively, in R1, 
Bm1438, ATCC 30222, ATCC PRA-99, GreenwichYale_Lab_Strain_1, Nan_Hs_2011_N11_50, and Naushon. 
SNP color-code relative to GI: non-synonymous in red; synonymous in green; UTR SNPs in purple; intron and 
intergenic SNPs in blue. The inner-most circle shows the location of variable loci, with the genomic position 
shown to scale. The vast majority of SNPs are fixed differences in R1 (track 3), relative to all other strains. 
Loci that encode the ten most immuno-dominant proteins are highlighted (radial yellow, in chromosomes 
1–3; letter-coded). Letter-coded loci also include the 27 most polymorphic genes, which together contain 
nearly 1/3 of all non-synonymous mutations. Letter code: Chr1: A, BBM_01g00480; B, BBM_01g00985; 
C, BBM_01g00996; D, BBM_01g01915; E, BBM_01g02065; F, BBM_01g02135; G, BBM_01g02415; H, 
BBM_01g03070. Chr2: A, BBM_02g00010; B, BBM_02g00896; C, BBM_02g01030 D, BBM_02g01290; 
E, BBM_02g01490; F, BBM_02g01825; G, BBM_02g03140; H, BBM_02g04250; I, BBM_02g04260; J, 
BBM_02g04265; K, BBM_02g04280. Chr3: A, BBM_03g00006; B, BBM_03g00690; C, BBM_03g00785; 
D, BBM_03g00885; E, BBM_03g00947; F, BBM_03g02345; G, BBM_03g03430; H, BBM_03g03985; I, 
BBM_03g04060; J, BBM_03g04135; K, BBM_03g04695; L, BBM_03g04760. Chr4: A, BBM_04g05770; B, 
BBM_04g06095; C, BBM_04g06375; D, BBM_04g07535; E, BBM_04g09150; F, BBM_04g09980.
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small multigene families (Tpr, Vesa, Rhomboid, CRMP, PSOP, LCCL and CPW-WPC)26,39–45. More than half of 
the genes encoding components of the B. microti secretome are unique to this species. 299 of which encode hypo-
thetical proteins, including 82 that have homologs in P. falciparum. Whereas approximately 60% of all B. microti 
proteins have homologs in P. falciparum, that proportion is only 36% among the 420 proteins of the B. microti 
secretome46–50. Conversely, of the > 500 P. falciparum proteins predicted to be secreted (http://mpmp.huji.ac.il/), 
only 151 have homologs in B. microti. As evidence of major differences between B. microti and P. falciparum in 
their interaction with the host cell and its remodeling, none of P. falciparum red blood cell (RBC)-targeted pro-
teins are found in B. microti (Supplementary Table S8) and no homologs to the components of the P. falciparum 
PTEX translocon are found in this parasite51. Furthermore, of all the known microneme and rhoptry proteins of 
P. falciparum, only 16 are found in B. microti, including nine homologs of rhoptry-associated proteins (BmRAP1–9), 
homologs of components of the moving junction BmAMA1, BmRON2, BmRON4 and BmRON5, two homologs 
Figure 3. Comparative analysis of mutation frequency among B. microti isolates. (A) Pie charts illustrating 
the mutation frequency in coding sequences (CDS), introns and intergenic regions as a percentage of total base 
pairs in the genome (left) and as a percentage of all mutations found to be specific to R1 (middle) or found in 
other isolates but not R1 (right). (B) Pie charts illustrating the details of the mutation frequency in genes in R1 
(left) and other isolates (right).
Figure 4. Distribution of non-synonymous (NSY: black), and indels, read-through (RTH) and non-sense 
(NON) (light gray) mutations in B. microti coding sequences with at least 2 mutations. Genes carrying 
R1- specific mutations are indicated with (R), those carrying non-R1specific mutations are indicated with 
(O), and those genes carrying both R1 and non-R1 specific mutations are labeled with (− ). Genes located in 
chromosome ends are marked with (*). Genes encoding members of the BMN family are marked with (1) 
to indicate the BMN1 family and (2) for the BMN2 family. Antigens depicted are GPI-anchored protein (G), 
transmembrane proteins (T) and secreted proteins (S). Genes encoding members of the secretome with non-R1 
specific mutations are highlighted in gray.
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of the rhoptry bulb constituents (BmRhopH2 and BmARO) and another microneme protein BmPLP152 (Fig. 7C). 
Interestingly, a homolog of the endoplasmic reticulum protease Plasmepsin V (BBM_04g05270), proposed to 
play a role in the processing of some secreted proteins in P. falciparum53, is found in the B. microti proteome, albeit 
with little sequence homology in the C-terminus part of the aspartyl protease A1 domain (Supplementary Fig. 2). 
No protein homologs of the targets of Plasmepsin V in P. falciparum46,48,49, T. gondii54 or B. bovis55 could be 
found in B. microti. New studies are needed to identify possible targets of the Plasmespin V–like peptidase from 
B. microti.
RNAseq analysis showed that while some of the genes encoding members of the B. microti secretome are 
highly expressed during blood stage infection, others are either not expressed or expressed at very low levels 
Figure 5. Comparison of expression levels of genes carrying at least one mutation. *Number of isolates 
where gene expression shows a 3-fold difference from the median of the six tested isolates. §Number of 
mutations found in CDS, intron, 5′ UTR and 3′ UTR. (A) Loci with R1-specific mutations (n= 383). (B) Loci 
with non-R1-specific mutations (n= 105).
Figure 6. Comparative analysis of mutation frequency in chromosome ends of B. microti isolates. (A) Pie 
charts illustrating the mutation frequency in chromosome ends and coding core of chromosomes I to IV as a 
percentage of total base pairs in the genome (left), and as a percentage of all mutations found to be specific to R1 
(middle) or those found to be isolate specific (right). (B) Clustering analysis of B. microti isolates based on 12 
microsatellite markers. *Conserved nodes observed in clustering based on differentially expressed genes.
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during this phase of the parasite life cycle (Fig. 1). Members of the sub-telomeric multigene families, including the 
Tpr-like genes, are expressed but at different levels, suggesting that they are independently regulated.
Differential gene expression among B. microti isolates. Transcriptional analysis showed a few major 
differences in expression levels among B. microti genes, with secretome protein classes being among the most var-
iable (Figs 1 and 8A–I). The three most expressed genes in B. microti in both mice and hamsters are those encod-
ing the GPI-anchored proteins BmGPI12 and BmGPI13 and the sugar:H+ symporter BmHT1. Comparison 
of gene expression between different isolates shows that the vast majority of the genes are similarly expressed 
in all isolates, with correlation of gene expression between each pair of isolates ranging from 81% and 94%. 
However, there are some noticeable exceptions, with 410 genes (including 33 rRNA and tRNA genes) that are 
differentially expressed among strains (defined as RPKM differing by more than 3 fold from the median RPKM; 
Supplementary Table S8), with differences between isolates surpassing 30 fold. The threshold was benchmarked 
using several housekeeping genes including the 18S rDNA, and the genes encoding B. microti translation elonga-
tion factor EF1α and EF1β , glyceraldehyde-3-phosphate dehydrogenase, succinate dehydrogenase subunits and 
lactate dehydrogenase (Fig. 8A–C). Thirty nine genes showed differential expression with levels of expression at 
least 10X higher or lower than the median. These include members of the putative parasite secretome as well as 
a neck kinase 4 ortholog (BmNEK4: Bm_03g00715), which was highly expressed only in the B. microti ATCC-
30222 isolate (Fig. 8F). Other genes showed differential expression in at least 2 isolates, and include six encoding 
hypothetical proteins and members of the parasite secretome.
Different B. microti isolates showed different host specificity, and therefore we have also compared 
host-dependent expression differences between isolates. Using EdgeR and DEseq2 methods to correlate gene 
expression to host specificity, 59 genes were identified in both analyses (Fig. 8G–I); 47 were up-regulated in iso-
lates grown in hamsters, and 12 genes were up-regulated in isolates propagated in SCID mice. Of the 59 genes, 
50 were found to be differentially expressed between isolates grown in different hosts with at least 3-fold increase 
or decrease in expression (Supplementary Fig. 3). Twenty-seven of these genes encode proteins with unknown 
function, whereas twelve are members of the secretome and six are involved in the regulation of protein expres-
sion, including the E3-ubiquitin ligase subunit, elongation factor eIF1B subunit and the mitochondrial subunit 
S8. Trafficking and cytoskeleton-related functions were attributed to three and two proteins, respectively. The 
secretome group includes three BmS48/45 genes, encoding the GPI-anchored antigen homolog of the P. falci-
parum sexual stage antigen Pfs48/45, which are highly expressed in parasites grown in hamsters.
The high prevalence of candidate antigen-encoding genes among differentially expressed B. microti genes, and 
the fact that these genes are twice as likely to be polymorphic as other parasite genes, suggest a possible role for 
these antigens in immune modulation.
Figure 7. B. microti host-presented antigen dataset. (A) Venn diagram illustrating the composition of the 
B. microti set of proteins targeted to the mitochondria, apicoplast and the secretome. Identification of the 
mitochondrial and apicoplast sets of proteins helped curate the main constituents of the secretome, from which 
the organelle-targeted genes were excluded. (B) Overlap between secretome-encoding genes and genes that 
either harbor SNPs and indels, are ranked in the top 10 most expressed B. microti genes, or are differentially 
expressed between isolates. (C) Model of the moving junction core complex of B. microti predicted based on the 
updated genome annotation.
www.nature.com/scientificreports/
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Immunoproteomic analysis of B. microti major antigens. In order to identify B. microti proteins 
that trigger a humoral immune response, we developed a reverse phase, antigen down, protein array consisting 
of 174 predicted proteins. We screened the array using pre-immune as well as immune sera collected from wild 
type Swiss Webster mice at days 4, 8, 12, and 16 following inoculation with B. microti Lab Strain 1. Whereas 
no antibodies could be detected with naïve, pre-immune sera, analysis of the kinetics of the humoral immune 
response associated with B. microti infection phase identified several new antigens, 62% of which were constit-
uents of the B. microti secretome (Figs 9 and 10). Detectable levels of IgM antibodies were measured as early 
as day 4 post-infection and increased significantly over time, peaking at day 8 and remaining high until day 16 
post-infection (Figs 9 and 10). In contrast, IgG antibodies were very low at day 4 and increased over time reach-
ing their peak at day 16 (Figs 9 and 10). The immune signature of the top 20 IgG or IgM most highly antigenic 
proteins identified 30 proteins (Fig. 9). Nearly half (14/30) are part of the secretome (5 GPI, 6 SEC and 3 TM). 
Only four genes are polymorphic, with one variable site each (SNP or indel). Interestingly, all US isolates outside 
R1 encode the same allele in each of those loci. Analysis of the protein array data resulted in the identification 
of three subsets of 10 proteins each. The first set includes proteins that trigger strong IgM and IgG responses 
starting at day 4 for the former and at day 8 for the latter, and remain high until day 16. This subset includes 
BmGPI12/BmSA1 (BBM_01g00985), a secreted S1/P1 nuclease (BBM_02g03140), BmRON2 (BBM_03g04695) 
and two secreted hypothetical proteins (BBM_01g00985 and BBM_03g00947). With the exception of BmGPI6 
and BmGPI17 (BBM_02g00896 and BBM_03g03430 respectively), all genes encoding antigens in this subgroup 
are among the top 10% most expressed genes in B. microti. The strongest immunogenic responses were obtained 
against BBM_01g00985- and BBM_03g00947-encoded peptides, both of which are part of the secretome. Both 
genes contain non-synonymous polymorphisms (Supplementary Table S8), including a variable microsattelite 
in BBM_03g00947 which supports the three groupings shown in Fig. 6B. In addition, BBM_03g00947 is down-
regulated in the Naushon strain relative to the other isolates. The second subset consists of proteins that trigger 
a significant IgG response that increases over time, and peaks between days 12 and 16, but induced only a mod-
erate to weak IgM response over the 16-day period. Most notable among these are three GPI-anchored proteins 
(BmGPI9 and 10) and the N1–15 maltese-cross seroactive antigen orthologue (BBM_04g07535). Seven of the 
proteins in this set are members of the secretome. The third subset includes proteins that trigger a strong immune 
IgM response and a low to weak IgG response. Half of the antigens in this group are members of the secretome 
including BmRON5 and two members of the BMN2 family.
Discussion
In this study we have combined genomic sequencing of seven B. microti isolates with transcriptomic analyses 
to systematically characterize the diversity of this emerging pathogen. Our sequencing of seven new isolates 
and re-sequencing of the R1 reference genome confirmed the previous genome analysis, which indicated that 
B. microti has the smallest apicomplexan genome available to date, and is among the most gene-dense. Draft 
genome assemblies generated for the different isolates confirmed a genome size around 6.5 Mb (Table S2), approx-
imately one-fourth the size of Plasmodium genomes. Despite the significant difference in genome size, a careful 
Figure 8. Heatmap of the log-transformed relative expressions of 410 genes considered as differentially 
expressed among 6 B. microti isolates. The gene expression was characterized as the log3 of the ratio between 
expression level in a specific isolate over the median of the expression levels in the 6 isolates. The distance 
between genes is the Euclidean distance. Ward metrics was used to obtain the dendrogram. Ten gene clusters 
could be characterized after classification.
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manual curation of gene models, facilitated by RNAseq data, showed the total number of B. microti-encoded 
genes to be 3567, almost two thirds the number in the P. falciparum genome, which consists of 5324 genes. The 
parasite secretome consists of 420 proteins, over 10% of its proteome. Secretion of these proteins to the host 
membrane or environment to remodel the host cell, acquire nutrients, or modulate the host immune response 
most likely involve the standard secretion pathway. Our analysis showed that no components of the Plasmodium 
translocon exist in B. microti, and that no homologues of proteins secreted through the translocon pathway are 
found in B. microti. Analyses based on sequence similarity failed also to suggest the use of other known secretion 
pathways, such as those associated with dense granules in Toxoplasma gondii54 or spherical bodies in Babesia 
bovis55. The role of the Plasmepsin V–like peptidase found in B. microti remains to be clarified in the absence of 
large multigene families.
By comparing the sequences of seven new B. microti isolates with the genome of the reference R1 isolate, 
we have identified only a total of close to 900 variable sites, including 588 SNPs and 301 indels. An analysis 
of the distribution of SNP-associated parameter values for each parameter considered, together with amplicon 
sequencing-based validation, was critical for the accurate identification of SNPs and in particular the elimination 
of false positive variants. The extraordinarily low sequence polymorphism found among these isolates, which 
originate primarily (but not uniquely) from the Northeast region of the United States, suggest that they all share a 
very recent common ancestor, possibly in the hundreds of years, assuming a mutation rate similar to other eukar-
yotes56. However, this finding needs to be confirmed with a more extensive population survey, accurately identi-
fied sequence variants, and coalescent modeling. Quite surprising is the lack of sequence divergence between the 
isolate ATCC 30222, thought to be originally from Zaire, and the remaining isolates, all of which are believed to 
Figure 9. Humoral immune response against the B. microti secretome. An antigen down protein array 
consisting of 198 selected B. microti polypeptides corresponding to 174 unique proteins and screened it using 
pre-immune as well as immune sera collected from wild type Swiss Webster mice at days 4, 8, 12, and 16 
following inoculation with B. microti LabS1 strain. Heatmaps for all 198 polypeptides were generated with the 
IgG (A) and IgM (B) intensity data. The color scale goes from white > grey > red representing low > mid > high 
serum reactivity to the spots. Each row is a feature/protein on the microarray and each column is a sample. A 
zoomed in view for the top 20 reactive antigens with row labels was also generated (C,D). This same data was 
used to create a line graph for the top 20 reactive antigens to show binding kinetics for IgG (E) and IgM (F) 
antibodies more clearly.
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originate from the Northeast United States. This issue that might require additional investigation to ensure the 
provenance of this ATCC isolate.
Three major variation-associated patterns were found among the B. microti isolates examined in this study. 
First, the R1 isolate appears significantly different from all other isolates with R1-specific mutations representing 
90% of all microsatellites and nearly 70% of all SNPs and small indels. Re-sequencing of the R1 isolate further 
validated the uniqueness of the R1 genome. Interestingly, R1 was isolated from a babesiosis patient who likely 
contracted the disease in Nantucket, MA. It is possible that the R1 isolate represents a different B. microti lineage 
from all other isolates. A recent study by Lemieux and colleagues56, released while this article was under review, 
suggests that all non-R1 isolates sequenced here likely belong to a New England lineage of B. microti separate 
from that containing the R1 reference. Second, non-R1 specific mutations, and differences in gene expression 
among isolates, are significantly associated with chromosome ends, a pattern similar to the accumulation of new 
mutations documented in other apicomplexans57,58. Finally, much of the non-synonymous variation identified 
among isolates falls disproportionately in a small number of genes, including many members of the secretome, 
suggestive of immune system-related selective pressure.
Immuno-proteomic analyses show that few members of the secretome induce IgM and/or IgG responses 
(Fig. 9). Among them, the BmSA1 antigen (BBM_03g00785) has already been placed among the most promising 
proteins for the development of a detection assay for B. microti in blood samples19. Two other proteins from the 
secretome provide even stronger signal by reverse phase analysis in mice: BBM_01g00985 and BBM_03g00947. 
Combined analysis of the genome-wide variation, transcriptome and immuno-proteome further confirmed the 
relevance of the GPI-anchored protein set in parasite-host interaction. The GPI-anchored proteome of B. microti 
is composed of only 19 proteins19, but six were found to be among the 20 proteins inducing the strongest IgG or 
IgM responses. We also found that nine of GPI-anchored proteins were among the top ten most highly expressed 
genes, among the set of genes harboring non-synonymous mutations and/or among the set of differentially 
expressed genes (Fig. 5). All genes from the BMN2 family are among these proteins. Nine of these were members 
of the secretome but they show little immunogenicity, suggesting a possible role in antigenic variation.
It remains unknown whether B. microti host preference can be linked to specific genetic determinants. 
However, two new lines of evidence generated in this study support this possibility. First, RNAseq analysis 
revealed 59 parasite genes with significantly different expression levels between isolates grown in different rodent 
host systems. In addition, our attempts to propagate these isolates in small rodents revealed clear host preferences.
In conclusion, our genomic and transcriptomic analyses of B. microti isolates provides initial evidence that 
B. microti strains from the Northeast region of the U.S. are not highly diverse and that most polymorphisms in 
this parasite are found in genes encoding proteins likely to be involved in host-pathogen interactions. Several 
antigens might prove useful in the development of a specific and sensitive assay for rapid detection of B. microti 
infection as well as for antibody-based targeted therapy.
Figure 10. Progression of the IgM and IgG responses in mice overtime as determined by immunoproteomic 
analysis. (A) IgM and IgG signals measured on a protein array for each individual mouse over time. (B) Median 
of the IgM or IgG responses determined for 174 B. microti proteins.
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Material and Methods
Ethics statement. All animal experimental protocols followed Yale University institutional guidelines for 
care and use of laboratory animals and were approved by the Institutional Animal Care and Use Committees 
(IACUC) at Yale University (Protocol #2010-07689). Yale University is accredited by the American Association 
for Accreditation of Laboratory Animal Care (AAALAC Number 101), and has an approved Animal Welfare 
Assurance (#A3230-01, effective until 5/31/2011) on file with the NIH Office for Protection from Research Risks. 
Rules for ending experiments in animals were to be enacted if animals showed any signs of distress or appeared 
moribund. This, however, was not the case for any animals in the study.
Animals. CB17/Icr-Prkdcscid/IcrIcoCrl mice and Golder Syrian Hamsters were purchased from Charles River, 
Inc. Animals were inoculated with infected blood via i.p. injection and monitored for infection. Parasitemia was 
determined using standard methods for collecting a drop of blood from the tail vein and using this blood to per-
form Giemsa staining.
B. microti Isolates. Babesia microti isolates used in this study are: GreenwichYale_Lab_Strain_1 (Lab_
Strain_1), a tick isolate propagated in mice and kindly provided by Dr. Durland Fish. Two isolates obtained 
from BEI Resources: ATCC-30222, and ATCC-PRA99. Two isolates kindly provided by Dr. Sam Telford: GI 
and Naushon. Two clinical isolates obtained from blood collected from babesiosis patients in 2011 and 2014, 
respectively: Nan_Hs_2011_N11-50 (N11-50) and Bm1438. These isolates were injected into SCID mice and/
or hamsters and infection was monitored for at least 2 months by microscopy analysis of Giemsa-stained blood 
(Supplemental Table 1).
Serum collection. Mouse sera were collected as follows. Five 6-week old female Swiss Webster mice were 
used to collect blood on day 0 (pre-immune sera) prior to infection with the B. microti LabS1 strain. Infection 
was achieved by IP injecting of 107 iRBCs previously collected from an infected SCID mouse. Blood was then 
collected from the five mice on days 4, 8, 12 and 16 in microcentrifuge tubes and left at room temperature for 
3 hours. After centrifugation at 4 °C for 10 minutes at 13,000 rpm, the serum fraction was collected in microcen-
trifuge tubes and stored at − 80 °C until used. All animal experimental protocols followed Yale University institu-
tional guidelines for care and use of laboratory animals and were approved by the Institutional Animal Care and 
Use Committee (IACUC) at Yale University.
Genome and RNA sequencing, assembly, structural and functional annotation, and differential 
gene expression analyses. Detailed protocols for genome and RNA sequencing of B. microti isolates are 
provided in Supplemental Methods.
Identification of variable mini- and microsatellites, single nucleotide polymorphisms (SNPs) 
and Nsmall indels. Tandem Repeat Finder (TRF)59 was used to identify all micro-satellites and mini-satellites 
(mx-satellites) in the reference B. microti R1genome assembly25. In house Perl scripts were used to extract unique 
sequences flanking the identified mx-satellites. Then, the BLAST60 aligner was used to locate each of the unique 
flanking sequences in other B. microti isolate, hence revealing the presence and copy number of mx-satellites homol-
ogous to those in the reference R1 genome. In-house Perl scripts were used to determine length and copy number 
variability of mx-satellites in each isolate compared to reference R1. Bedtools61 was used to determine if a microsat-
ellite was present in the exonic, intergenic or intronic region in the genome.
To identify SNPs and small indels, whole genome shotgun sequencing data for each of the strains was aligned 
to the reference B. microti R1 genome25 using BWA62. Data was formatted using SAM tools63 and Picard tools 
v.1.79 (http://broadinstitute.github.io/picard), and SNP variant calling and filtering using the Genome Analysis 
Toolkit GATK, UnifiedGenotyper, v2.2.564. In order to remove potential false positives. identified variants were 
filtered according to the following parameters values: (DP < 12) || (QUAL < 50) || (SB > − 0.10) || (MQ0 > = 2 
&& (MQ0/(1.0 * DP)) > 0.1). SNPs that passed filter were attributed to non-coding or coding regions 
using VCFannotator (http://sourceforge.net/projects/vcfannotator) in the context of the reference genome 
re-annotation annotation.
Two approaches were then used to define true variations in the set of B. microti genomes. The first variant 
approach calling using parameters described above provide a list of 1490 possible variation sites where more than 
95% were single point mutations. Indels were analyzed differently from SNP. All indels were kept for further anal-
ysis whereas the choice of GATK parameters was trained for the choice of the correct filtering threshold. Sanger 
sequencing of PCR products was performed for six loci: BBM_01g00985, BBM_02g04060, BBM_02g04280, 
BBM_03g00885, BBM_03g04060, BBM_04g09150. None of the variation described in the vcf files in these 
regions could confirmed at experimental level. Analysis was done on the 8 strains for loci BBM_02g04280 and 
BBM_03g04060 and on R1 only for the four other loci. Sequencing confirms the need for a specific and stringent 
variant calling method. All GATK parameters computed using default option were tested for the signal they pro-
vide and correspondence with training mutations. The histogram of several parameter including the ABHom, DP 
and MQ value was constructed per isolate for each SNP positions. The ABHom parameter evaluating homozy-
gosis at a locus provide valid information over the threshold of 0.85. MQ and DP parameters were also analyzed. 
We keep SNP position where MQ was over 58. DP had no impact after these two threshold were chosen but in 
some isolates, DP could be equal to zero in some isolate and this information was identified as uncovered region. 
We found 889 (588 single point mutations and 301 insertions/deletions) highly reliable variants in the nuclear 
genome after analysis of eight NGS sequence.
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Strain clustering Analyses based on sequence variation. Unsupervised hierarchical clustering was 
performed for 7 samples based on 12 variable microsatellites. The pairwise distance between the samples was 
calculated as the proportion of base substitutions between them over the number of variable microsatellites, i.e. 
for pair of isolates (number of pairwise differences)/(total number of variable sites). Unsupervised hierarchical 
clustering was also performed based on RNAseq data for 146 differentially expressed genes. Pairwise distance 
among 6 isolates was calculated as the Euclidean distance. The Ward minimum variance method was used as 
a metric to build the dendrogram in R for both approaches. Conserved nodes were identified between the two 
clustering results.
Immunoproteomic analyses. Detailed protocols for cloning of B. microti cDNAs, microarray fabrication 
and immunoproteomic analyses are provided in Supplemental Methods.
Statistical analysis of antibody binding intensity. The data matrix of the compiled intensity data, 
or “raw” immuno-proteomic data files, were imported in the statistical programing environment R (https://
www.r-project.org/). The normalization procedure was as follows: (1) Peak intensity was normalized to the sum 
of all signals on the array for B. microti spots, and (2) intensity of each spot was calibrated to the maximum signal 
detected in the array. The normalized data (range between 0 and 100%) provide a relative measure of the B. microti 
antigenic response over time compared to day 16 where samples show maximum signal intensity. The data were 
grouped by time point and sorted by reactivity, and visualized using the RColorbrewer R package to create the 
color scheme and the gplots R package to generate the heatmap.
Data Access. Accession numbers for WGS read alignments on reference genome bam files, de novo assem-
blies and RNAseq reads are given in Additional File 2: Table S2. The updated annotation of nuclear chromosomes 
1–4 will be associated with features with accession number FO082871, FO082872, LN871598 and LN871598, 
respectively.
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